Alternative lipid lowering therapy		Number of Patients	Absolute change in lipid parameters		Average duration of therapy (Months)	Cardiovascular event during therapy
Alternative lipid lowering therapy		Number of Patients	Total Cholesterol (%)	LDL-cholesterol (%)	Average duration of therapy (Months)	Cardiovascular event during therapy
Alternative statin only	Low dose statin	15	−10.3	−14	10.2	1
Alternative statin plus non-statin lipid lowering therapy	Statin plus ezetemibe	15	−28.5	−37.3	10.9	1
	Statin plus fibrate	3	−11.2	−16.2	6	0
	Statin plus bile acid sequestrant	1	0	+2.2	10.0	0
	Statin plus more than one non-statin therapy	6	−16	−4	9.8	0
Non-statin lipid lowering therapy only	Ezetemibe	3	+17.7	+21.7	9.6	0
	Fibrate	2	−29	−32.1	10.5	0
	Bile acid sequestrant	2	+5.5	0	11	0
	Omega 3 fatty acid	3	+5.1	+25	15.5	0